Guardion Health Sciences Overview
Valuation check: GHSI's P/E ratio is 27.08, above the Healthcare sector average of 24.78.
Get informed when a big investor buys or sells
+ Follow27.08
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Guardion Health Sciences's p/e ratio stands at 27.08. That is above the Healthcare sector average of 24.78. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Guardion Health Sciences sits higher the Healthcare benchmark (24.78) with a P/E ratio of 27.08. That is roughly 9.3% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 27.08 is attractive depends on Guardion Health Sciences's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Guardion Health Sciences's P/E ratio evolved across reporting periods, while the comparison chart places GHSI next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, P/E ratio is commonly used to spot outliers. Guardion Health Sciences's reading of 27.08 (sector avg 24.78) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
